Silence Therapeutics annual revenue
2022
2023
2024
2025
Silence Therapeutics Revenue Growth & History (SLN)
Silence Therapeutics reported $559,000 in revenue for fiscal 2025, a decrease of 98.71% from the previous fiscal year.
View full Silence Therapeutics company overviewSilence Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $559,000 | −$42.7M | −98.71% |
| 2024 | 2024-12-31 | $43.3M | $11.6M | +36.71% |
| 2023 | 2023-12-31 | $31.6M | $10.0M | +46.12% |
| 2022 | 2022-12-31 | $21.7M | — | — |
Silence Therapeutics quarterly revenue
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$224,000 | −100.00% |
| Q1 2026 | 2026-03-31 | $422,000 | $280,000 | +197.18% |
| Q4 2025 | 2025-12-31 | $34,000 | −$25.3M | −99.87% |
| Q3 2025 | 2025-09-30 | $159,000 | −$1.3M | −89.39% |
| Q2 2025 | 2025-06-30 | $224,000 | −$532,000 | −70.37% |
| Q1 2025 | 2025-03-31 | $142,000 | −$15.6M | −99.10% |
| Q4 2024 | 2024-12-31 | $25.3M | — | — |
| Q3 2024 | 2024-09-30 | $1.5M | — | — |
| Q2 2024 | 2024-06-30 | $756,000 | — | — |
| Q1 2024 | 2024-03-31 | $15.7M | — | — |
Silence Therapeutics revenue growth trends
Silence Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Silence Therapeutics source filings ↗